A short explainer for newcomers placing Ozempic, Wegovy, Mounjaro and Zepbound in the same molecule family that health and longevity circles keep discussing.
Recap by typeshit. Post by @drrekhakumar on Instagram.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Users most often reported increased appetite, unlike the stomach issues seen in trials. The authors say it proves nothing causal and only flags leads to test.
Lexaria says some DehydraTECH formulas hit its best absorption yet and filed 3 patents. Semaglutide brain levels were too low to measure in this rat study.
Loading…